[Perspectives in treatment of peptic ulcer disease].
Arakawa
Tetsuo
T
Department of Gastroenterology, Osaka City University Graduate Medical School.
Higuchi
Kazuhide
K
Matsumoto
Takayuki
T
Oshitani
Nobuhide
N
Fujiwara
Yasuhiro
Y
Tominaga
Kazunari
K
Watanabe
Toshio
T
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects; D000906:Antibodies / Q000627:therapeutic use; D016207:Cytokines / Q000037:antagonists & inhibitors / Q000276:immunology; D004358:Drug Therapy / Q000639:trends*; D005544:Forecasting; D016481:Helicobacter Infections / Q000150:complications / Q000188:drug therapy; D006801:Humans; D018836:Inflammation Mediators / Q000037:antagonists & inhibitors / Q000276:immunology; D010431:Pentoxifylline / Q000494:pharmacology / Q000627:therapeutic use; D010437:Peptic Ulcer / Q000188:drug therapy* / Q000209:etiology; D018121:Receptors, Cytokine / Q000276:immunology; D012008:Recurrence; D016896:Treatment Outcome
D000894:Anti-Inflammatory Agents, Non-Steroidal; D000906:Antibodies; D016207:Cytokines; D018836:Inflammation Mediators; D018121:Receptors, Cytokine; D010431:Pentoxifylline